Bioinformatic analysis revealed that several immune-related pathways were activated within tumor tissues following therapy with B7-H3 CAR-T cells, including signaling pathways associated with interferons, interleukins, chemokines, T-cell receptors (TCR) and others (Fig. 5c, d and Fig. S5). This evidence concerns the gene CD276 and neoplasm.